272 related articles for article (PubMed ID: 30718981)
1. LXRs, SHP, and FXR in Prostate Cancer: Enemies or
Cariello M; Ducheix S; Maqdasy S; Baron S; Moschetta A; Lobaccaro JA
Nucl Recept Signal; 2018; 15():1550762918801070. PubMed ID: 30718981
[TBL] [Abstract][Full Text] [Related]
2. New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors.
Bousset L; Rambur A; Fouache A; Bunay J; Morel L; Lobaccaro JA; Baron S; Trousson A; de Joussineau C
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154328
[TBL] [Abstract][Full Text] [Related]
3. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
Xiao J; Gong AY; Eischeid AN; Chen D; Deng C; Young CY; Chen XM
Prostate; 2012 Oct; 72(14):1514-22. PubMed ID: 22314666
[TBL] [Abstract][Full Text] [Related]
4. Small heterodimer partner SHP mediates liver X receptor (LXR)-dependent suppression of inflammatory signaling by promoting LXR SUMOylation specifically in astrocytes.
Lee JH; Kim H; Park SJ; Woo JH; Joe EH; Jou I
Sci Signal; 2016 Aug; 9(439):ra78. PubMed ID: 27485016
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist.
Chuu CP; Hiipakka RA; Kokontis JM; Fukuchi J; Chen RY; Liao S
Cancer Res; 2006 Jul; 66(13):6482-6. PubMed ID: 16818617
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology.
Oumeddour A; Viennois E; Caira F; Decourbey C; Maqdasy S; Tahraoui A; Baron S; Volle DH; Lobaccaro JM
Biochem Biophys Res Commun; 2014 Apr; 446(3):656-62. PubMed ID: 24333430
[TBL] [Abstract][Full Text] [Related]
7. Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.
Bousset L; Septier A; Bunay J; Voisin A; Guiton R; Damon-Soubeyrant C; Renaud Y; De Haze A; Sapin V; Fogli A; Rambur A; De Joussineau C; Kocer A; Trousson A; Henry-Berger J; Höring M; Liebisch G; Matysik S; Lobaccaro JA; Morel L; Baron S
PLoS Biol; 2020 Dec; 18(12):e3000948. PubMed ID: 33284790
[TBL] [Abstract][Full Text] [Related]
8. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.
Edwards PA; Kast HR; Anisfeld AM
J Lipid Res; 2002 Jan; 43(1):2-12. PubMed ID: 11792716
[TBL] [Abstract][Full Text] [Related]
9. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
[TBL] [Abstract][Full Text] [Related]
10. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
Daniels G; Li Y; Gellert LL; Zhou A; Melamed J; Wu X; Zhang X; Zhang D; Meruelo D; Logan SK; Basch R; Lee P
Endocr Relat Cancer; 2014 Feb; 21(1):127-42. PubMed ID: 24243687
[TBL] [Abstract][Full Text] [Related]
11. Androgen deprivation by activating the liver X receptor.
Lee JH; Gong H; Khadem S; Lu Y; Gao X; Li S; Zhang J; Xie W
Endocrinology; 2008 Aug; 149(8):3778-88. PubMed ID: 18450964
[TBL] [Abstract][Full Text] [Related]
12. Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.
Kaeding J; Bouchaert E; Bélanger J; Caron P; Chouinard S; Verreault M; Larouche O; Pelletier G; Staels B; Bélanger A; Barbier O
Biochem J; 2008 Mar; 410(2):245-53. PubMed ID: 17988216
[TBL] [Abstract][Full Text] [Related]
13. The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity.
Brendel C; Schoonjans K; Botrugno OA; Treuter E; Auwerx J
Mol Endocrinol; 2002 Sep; 16(9):2065-76. PubMed ID: 12198243
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of orphan nuclear receptors in prostate cancer.
Wu D; Cheung A; Wang Y; Yu S; Chan FL
Biochim Biophys Acta; 2016 Aug; 1866(1):23-36. PubMed ID: 27264242
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between the androgen receptor and the liver X receptor: implications for cholesterol homeostasis.
Krycer JR; Brown AJ
J Biol Chem; 2011 Jun; 286(23):20637-47. PubMed ID: 21489984
[TBL] [Abstract][Full Text] [Related]
16. Does changing androgen receptor status during prostate cancer development impact upon cholesterol homeostasis?
Krycer JR; Brown AJ
PLoS One; 2013; 8(1):e54007. PubMed ID: 23320115
[TBL] [Abstract][Full Text] [Related]
17. [New pathophysiological mechanisms of metabolic syndrome: implication of orphan nuclear receptors?].
Kuhn E; Fève B; Lombès M
Ann Endocrinol (Paris); 2012 Oct; 73 Suppl 1():S9-16. PubMed ID: 23089382
[TBL] [Abstract][Full Text] [Related]
18. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells.
Chuu CP; Chen RY; Hiipakka RA; Kokontis JM; Warner KV; Xiang J; Liao S
Biochem Biophys Res Commun; 2007 Jun; 357(2):341-6. PubMed ID: 17416342
[TBL] [Abstract][Full Text] [Related]
19. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
[TBL] [Abstract][Full Text] [Related]
20. Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling.
Wang T; Song W; Chen Y; Chen R; Liu Z; Wu L; Li M; Yang J; Wang L; Liu J; Ye Z; Wang C; Chen K
Clin Cancer Res; 2016 Mar; 22(6):1531-44. PubMed ID: 26527749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
